Gabriel N Mannis MD
Assistant Professor of Medicine, Stanford Cancer Institute
Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Mannis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2011 - 2014- University of California (San Francisco)Residency, Internal Medicine, 2008 - 2011
University of California, Davis, School of MedicineClass of 2008
Certifications & Licensure
CA State Medical License 2010 - 2026
American Board of Internal Medicine Hematology
Clinical Trials
- Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies Start of enrollment: 2017 Sep 08
- Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia Start of enrollment: 2018 Oct 15
- Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML) Start of enrollment: 2021 Feb 09
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsV-FAST: a phase 1b master trial to investigate CPX-351 combined with targeted agents in adults with newly diagnosed AML.Vinod A Pullarkat, Mark Levis, James McCloskey, Gabriel N Mannis, Stephen A Strickland
Blood Neoplasia. 2025-11-01 - 1 citationsA phase 1 study of IO-202, an anti-LILRB4 antibody, in chronic myelomonocytic leukemia and acute myeloid leukemia.Ahmed Aribi, Gabriel N Mannis, Yazan F Madanat, Brian A Jonas, Neil Dunavin
Blood Neoplasia. 2025-11-01 - Optimizing capillary leak syndrome prevention and management in patients receiving tagraxofusp for blastic plasmacytoid dendritic cell neoplasm.Andrew A Lane, Cristina Papayannidis, Emanuele Angelucci, James McCloskey, Gary J Schiller
Leukemia & Lymphoma. 2025-10-24
Press Mentions
OncLive® Presents State of the Science Summit™: Hematologic MalignanciesDecember 5th, 2017
Risk-Reducing Salpingo-Oophorectomy and Ovarian Cancer Screening in 1077 Women After BRCA TestingJanuary 28th, 2013
Study Examines Risk Reduction and Screening for Ovarian Cancer Among Women Following BRCA TestingJanuary 29th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
